IVF/ICSI Protocols in Poor Responders With Growth Hormone

- The folks at Woman's Health University Hospital, Egypt are studying the effects of Growth hormone (Norditropin, Novo nordisk) on Female Infertility Due to Diminished Ovarian Reserve in females ages 20 years to 45 years. This clinical trial is slated to start September 2013 and is expected to end circa March 2014.

01003498919
Dina M Dakhly, MD
Overall Study Contact Info
StatusName Contact Phone
RecruitingDina M Dakhly, MDdinadakhly@gmail.com01003498919

This study is officially titled, "Which is the Best IVF/ICSI Protocol to be Used in Poor Responders Receiving Growth Hormone as an Adjuvant Treatment ? A Prospective Randomized Study."

Locations

private IVF medical center

Giza, Cairo - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.